Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Late Phase CRO Phase IV Medpace
Late Phase Clinical Research
request info
First Name*:
Last Name*:
Company*:
Email*:
Leave a Message:


Please enter the security code


Find out how our medical, regulatory, and operational expertise in late phase post-marketing clinical development can help with your next study or program.



GENERAL CAPABILITIES

VIEW NOW more

Late Phase Fact Sheet: Post-marketing Capabilities

Late Phase White Paper: White Paper: Early Planning for Late Phase Success

Risk Based Monitoring Webinar: Sponsors, CROs and RBM: Getting Aligned for Success

Risk Based Monitoring White Paper:The Role of the CRO in Effective Risk-Based Monitoring

Planning for and Conducting Late Phase Clinical Research

Medpace, long known for its therapeutic and regulatory capabilities, is well-resourced to assist with your post-approval strategies and to conduct Phase IIIb-IV studies in both pharmaceutical and medical device areas. Our global operational reach and full-service capabilities for Phase I-IV studies can help you achieve your scientific and commercial objectives.

How our epidemiology and late phase research team can help:

  • Develop integrated post-approval strategies with your early-stage clinical development plans
  • Medical, regulatory, clinical, and late phase experts are deeply embedded in your studies to provide strategic and operational leadership
  • A breadth of resources to conduct global research yet an agile culture that enables swift adaptability as study requirements shift
  • Targeted site selection reflecting real world drug and medical device use
  • Dedicated submissions team to accelerate startup
  • Global and localized regulatory leadership from early phase through late phase
  • Expertise, resources and infrastuture to transition from randomized controlled trial process to real-world implementation

Medpace conducts both interventional and non-interventional type studies:

  • Phase IIIb and IV randomized clinical trials
  • Observational epidemiologic studies
  • Expanded access programs
  • Post-authorization safety studies
  • Health Economics and Outcomes Research
  • Competitive marketing claims studies
  • Registries


Medpace's epidemiology and late phase research team engages with The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Being a partner centre of the ENCePP, Medpace is able to register appropriate studies we conduct on the ENCePP e-register, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies, which also serves as a EU PAS Register for Post-Authorization Safety Studies (PASS).


Registry Planning and Implementation

Listen to Derenda Nichols,Director of Clinical Trial Management, address factors that contribute to successful Registries. The presentation was recorded at the CBI Real World Data/Late Phase Research Summit.

Registry Planning and Implementation: An Operational Perspective from Medpace CRO .